✦ LIBER ✦

Mechanism of the immunosuppressive effect in vivo of novel immunosuppressive drug β-SQAG9, which inhibits the response of the CD62L+ T-cell subset

✍ Scribed by M. Takenouchi; H. Sahara; Y. Yamamoto; Y. Matsumoto; A. Imai; T. Fujita; Y. Tamura; N. Takahashi; S. Gasa; K. Matsumoto; K. Ohta; F. Sugawara; K. Sakaguchi; K. Jimbow; N. Sato

Book ID: 116930818
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 99 KB
Volume: 37
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2004.12.204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of CD62L+ T-cell response in

Inhibition of CD62L+ T-cell response in vitro via a novel sulfo-glycolipid, β-SQAG9 liposome that binds to CD62L molecule on the cell surface

✍ Yoshiteru Yamamoto; Hiroeki Sahara; Mika Takenouchi; Yoshitaka Matsumoto; Akihit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 791 KB

CYCLOSPORIN A INHIBITS THE IN VIVO PRODU

CYCLOSPORIN A INHIBITS THE IN VIVO PRODUCTION OF INTERLEUKIN-1β AND TUMOUR NECROSIS FACTOR α, BUT NOT INTERLEUKIN-6, BY A T-CELL-INDEPENDENT MECHANISM

✍ Janet Dawson; Ursula Hurtenbach; Andrew MacKenzie 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB